Closing The Diversity Gap In Clinical Trials
Forbes: 4/09/2014 Clinical trials are at the heart of the process for bringing new medicines to patients. While modern researchers can do more with molecules in the laboratory than ever before, and preclinical analysis of a compound can provide important evidence about its potential value in treating disease, it’s impossible to determine the safety and effectiveness […]
Recruiting and motivating black subjects to complete a lengthy survey in a large cohort study: an exploration of different strategies
BMC Medical Research Methodology: April 3, 2014 Background The effectiveness of multiple innovative recruitment strategies for enrolling Black/African American participants to the Adventist Health Study-2 (AHS-2) is described. The study’s focus is diet and breast, prostate and colon cancer. Methods Promotions centered on trust, relationship building and incentives for increasing enrollment and questionnaire return rate. Of […]
Clinical trials: clearer rules, better protection for patients
Europarl: 02-04-2014 Pharmaceutical companies and academic researchers will have to post the results of all their European clinical trials in a publicly-accessible database, under a draft law already informally agreed with EU ministers and passed by Parliament on Wednesday. The law also facilitates cross-border cooperation to make clinical trials larger, more viable and more reliable, which […]
Enrollment of racially/ethnically diverse participants in traumatic brain injury trials: Effect of availability of exception from informed consent
Clin Trials: April 2014 Background The Final Rule regulations were developed to allow exception from informed consent (EFIC) to enable clinical trial research in emergency settings where major barriers exist for informed consent. There is little known evidence of the effect of the Final Rule in minority enrollment in clinical trials, particularly in traumatic brain injury (TBI) […]
20 Years Later, Drugs Do Act Differently in Women
Mar 31, 2014: By: Applied Clinical Trials Online: Lisa Henderson In January 2013, FDA told manufacturers to lower the dose of zolpidem for women, and suggested a 10 mg to 5 mg for immediate-release products (Ambien, Edluar, and Zolpimist) and from 12.5 mg to 6.25 mg for extended-release products (Ambien CR). That was based on evidence the drug is metabolized […]
Investigators
Clinical trial investigators, or physicians who want to become investigators, should CLICK HERE to join the Clinical Trial Engagement Network and enter their profile in the Investigator Registry of the Clinical Trial Recruitment Center.
Supplement: Enhancing minority participation in clinical trials (EMPaCT): Laying the Groundwork for Improving Minority Clinical Trial Accrual
Wiley: April 1, 2014 An overview of EMPaCT and fundamental issues affecting minority participation in cancer clinical trials: Enhancing minority participation in clinical trials (EMPaCT): Laying the groundwork for improving minority clinical trial accrual (pages 1087–1090)Selwyn M. Vickers and Mona N. FouadArticle first published online: 18 MAR 2014 | DOI: 10.1002/cncr.28569 This supplement provides an overview of […]
